Group One Trading
LPCN icon

Group One Trading’s Lipocine LPCN Stock Holding History

Group One Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338 Hold
132
– – ﹤0.01% 7340
2026
Q1 		$1.05K Sell
132
-30
-19% -$261 ﹤0.01% 7208
2025
Q4 		$1.3K Hold
162
– – ﹤0.01% 7653
2025
Q3 		$463 Hold
162
– – ﹤0.01% 8152
2025
Q2 		$512 Sell
162
-35
-18% -$114 ﹤0.01% 7656
2025
Q1 		$626 Hold
197
– – ﹤0.01% 7253
2024
Q4 		$961 Sell
197
-226
-53% -$1.15K ﹤0.01% 6897
2024
Q3 		$1.9K Buy
423
+407
+2,544% +$2.04K ﹤0.01% 6158
2024
Q2 		$132 Sell
16
-24
-60% -$150 ﹤0.01% 6541
2024
Q1 		$208 Sell
40
-12
-23% -$47 ﹤0.01% 6805
2023
Q4 		$144 Hold
52
– – ﹤0.01% 7182
2023
Q3 		$153 Hold
52
– – ﹤0.01% 7447
2023
Q2 		$260 Sell
52
-68
-57% -$320 ﹤0.01% 7442
2023
Q1 		$651 Buy
+120
New +$927 ﹤0.01% 6867
2021
Q2 		– Sell
-3,052
Closed -$71.8K – 8369
2021
Q1 		$78K Buy
+3,052
New +$88.1K ﹤0.01% 5871
2020
Q3 		– Sell
-2,209
Closed -$58.7K – 6349
2020
Q2 		$47K Buy
2,209
+283
+15% +$3.67K ﹤0.01% 4406
2020
Q1 		$16K Sell
1,926
-1,504
-44% -$11.9K ﹤0.01% 4351
2019
Q4 		$22K Buy
3,430
+3,158
+1,161% +$80.9K ﹤0.01% 4339
2019
Q3 		$13K Sell
272
-560
-67% -$22.5K ﹤0.01% 4513
2019
Q2 		$28K Hold
832
– – ﹤0.01% 4044
2019
Q1 		$33K Sell
832
-325
-28% -$9.97K ﹤0.01% 3790
2018
Q4 		$26K Sell
1,157
-236
-17% -$5.47K ﹤0.01% 3903
2018
Q3 		$33K Sell
1,393
-2,575
-65% -$63.3K ﹤0.01% 4195
2018
Q2 		$88K Buy
3,968
+213
+6% +$5.08K ﹤0.01% 3644
2018
Q1 		$98K Buy
+3,755
New +$105K ﹤0.01% 3259
2017
Q1 		– Sell
-296
Closed -$19.2K – 4829
2016
Q4 		$19K Buy
+296
New +$18.7K ﹤0.01% 3720

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Group One Trading's LPCN Position: Q2 2026 in Review

Group One Trading held its Lipocine (LPCN) position steady in Q2 2026 at 132 shares worth $338. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

Group One Trading first reported a position in LPCN in Q4 2016 and has held it in 26 quarters since. The position peaked at $98K in Q1 2018. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Group One Trading held 132 shares of Lipocine worth $338 as of Q2 2026.
  • Group One Trading left its Lipocine share count unchanged in Q2 2026.
  • Lipocine made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7340 holding.
  • Group One Trading first reported a position in Lipocine in Q4 2016 and has held it in 26 quarters since.
  • Group One Trading's Lipocine position peaked at $98K in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.